NCT03696433

Brief Summary

This study aims to assess the salt sensitive blood pressure response to dietary salt load compared with radiological markers of salt handling.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 4, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 4, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 4, 2022

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

January 15, 2025

Completed
Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

3.8 years

First QC Date

September 25, 2018

Results QC Date

November 5, 2023

Last Update Submit

April 3, 2026

Conditions

Keywords

salt sensitive, blood pressure, obesity, magnetic resonance imaging

Outcome Measures

Primary Outcomes (1)

  • Mean Arterial Blood Pressure Following High-salt Diet and Low-salt Diet

    Mean arterial pressure following high-salt diet, and low-salt diet.

    Following completion of all dietary supplements and washout, in no less than 21 days.

Study Arms (2)

Low- then high-salt diet

EXPERIMENTAL

10 subjects will be enrolled and each will undergo study procedures at 4 separate visits. Subjects will be randomly assigned to this study arm, differing in the order of low and high salt diets. After a baseline visit to include a noninvasive MRI scan, the subject will begin this study diet: low-salt diet, then washout consisting of the subject's typical diet, then high-salt diet. Each dietary or washout period lasts for 7 days, and study visits will occur after each period.

Dietary Supplement: Low-salt dietDietary Supplement: High-salt diet

High- then low-salt diet

EXPERIMENTAL

10 subjects will be enrolled and each will undergo study procedures at 4 separate visits. Subjects will be randomly assigned to this study arm, differing in the order of low and high salt diets. After a baseline visit to include a noninvasive MRI scan, the subject will begin this study diet: high-salt diet, then washout consisting of the subject's typical diet, then low-salt diet. Each dietary or washout period lasts for 7 days, and study visits will occur after each period.

Dietary Supplement: Low-salt dietDietary Supplement: High-salt diet

Interventions

Low-salt dietDIETARY_SUPPLEMENT

The low-salt diet (7 days) will consist of meals, snacks and water provided by Vanderbilt's metabolic kitchen.

High- then low-salt dietLow- then high-salt diet
High-salt dietDIETARY_SUPPLEMENT

The high-salt diet (7 days) consists of each subject's typical diet, supplemented each day with 2 bullion broth packets, which will be provided to the subject by the study staff.

High- then low-salt dietLow- then high-salt diet

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Identification as black race
  • Age between 18 and 55 years
  • Body mass index between 25 and \<35 kg/m2
  • Normotensive or pre-hypertensive
  • Willing to adhere to study diets
  • Able to provide informed consent and communicate with study personnel

You may not qualify if:

  • Prevalent cardiovascular disease or use of medications for cardiovascular disease
  • Current or prior history of hypertension or use of blood pressure lowering medications
  • Current or prior history of diabetes mellitus or use of anti-diabetic medications
  • Prevalent renal disease (eGFR \< 60 ml/min/1.73m2), abnormal serum sodium or potassium
  • Current or prior smoker
  • Current pregnancy, or use of hormone replacement therapy or oral contraceptive
  • Current steroid use
  • Contraindications to MRI
  • Active infection or open wounds on the top of the feet or hands

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37212, United States

Location

Related Publications (2)

  • Crescenzi R, Marton A, Donahue PMC, Mahany HB, Lants SK, Wang P, Beckman JA, Donahue MJ, Titze J. Tissue Sodium Content is Elevated in the Skin and Subcutaneous Adipose Tissue in Women with Lipedema. Obesity (Silver Spring). 2018 Feb;26(2):310-317. doi: 10.1002/oby.22090. Epub 2017 Dec 27.

    PMID: 29280322BACKGROUND
  • Crescenzi R, Donahue PMC, Hartley KG, Desai AA, Scott AO, Braxton V, Mahany H, Lants SK, Donahue MJ. Lymphedema evaluation using noninvasive 3T MR lymphangiography. J Magn Reson Imaging. 2017 Nov;46(5):1349-1360. doi: 10.1002/jmri.25670. Epub 2017 Feb 28.

    PMID: 28245075BACKGROUND

MeSH Terms

Conditions

Obesity

Interventions

Diet, Sodium-Restricted

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Results Point of Contact

Title
Cassandra Reynolds, BS, CCRC
Organization
Vanderbilt University Medical Center

Study Officials

  • Rachelle Crescenzi, PhD

    Department of Radiology, Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 25, 2018

First Posted

October 4, 2018

Study Start

February 1, 2019

Primary Completion

November 4, 2022

Study Completion

November 4, 2022

Last Updated

April 23, 2026

Results First Posted

January 15, 2025

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Locations